Wolverine Blend (BPC-157 + TB-500) 2mg — Vial Spec, Reconstitution Math & COA

Overview of Wolverine Blend (BPC-157 + TB-500) 2mg Specifications

The 2mg total mass formulation of the Wolverine Blend is a co-lyophilized combination consisting of 1mg Body Protection Compound-157 (BPC-157) and 1mg Thymosin Beta-4 synthetic fragment (TB-500). Manufactured under strict ISO 17025 laboratory quality controls, this micro-scale preparation enables researchers to evaluate dual-peptide signaling cascades without preparing separate solutions or incurring unnecessary reagent waste during small-scale exploratory trials.

In laboratory research settings, BPC-157 is a 15-amino acid pentadecapeptide (molecular mass: 1419.5 Da) recognized for its stability in aqueous solutions and structural role in growth factor modulation. TB-500 (molecular mass: 4963.5 Da for full-length Thymosin Beta-4, or specific bioactive terminal sequences) acts primarily as an actin-sequestering protein monomer regulator. When supplied in a combined 2mg vial, the two compounds exist as a homogeneous, white-to-off-white lyophilized cake sealed under inert nitrogen atmosphere to prevent premature oxidative degradation.

Principal investigators often select the 2mg format for early-stage pilot experiments, such as micro-fluidic cell motility assays, Western blot signal verification, or initial receptor binding studies where larger batch volumes would degrade over extended incubation schedules.

Catalog Availability & Custom Packaging Configurations at PX1 Research

PX1 Research maintains high-purity stock of research peptides synthesized in U.S.-based, GMP-compliant facilities. While small-volume operational units frequently request the 2mg composite vial for micro-scale testing, PX1 Research standardly stocks the higher-yield 5mg BPC-157 / 5mg TB-500 Wolverine Blend (10mg total combined lyophilized mass) within our standard catalog to provide optimal cost-per-milligram efficiency for medium- and high-throughput research platforms.

For specialized laboratory protocols that strictly require 2mg unit fill sizes to match microplate automated liquid handlers, custom batching and specialized packaging configurations are available directly through our bulk lab accounts division. Researchers evaluating single-agent control parameters alongside composite formulas can also review individual compounds within our complete catalog of research peptides, including standalone BPC-157 5mg research peptide and TB-500 5mg peptide units.

Synergistic Mechanisms in Preclinical Cell & Tissue Repair Models

Preclinical studies suggest that combining BPC-157 and TB-500 activates complementary, non-overlapping cellular pathways involved in structural matrix reorganization, cell migration, and focal adhesion dynamics. In vitro assays evaluating endothelial cell cultures demonstrate that BPC-157 promotes early extracellular matrix maintenance by upregulating vascular endothelial growth factor receptor 2 (VEGFR2) transcription and activating the focal adhesion kinase (FAK)-paxillin signaling pathway.

Conversely, in vitro data indicate that TB-500 functions by sequestering G-actin monomers, thereby modulating intracellular actin polymerization dynamics necessary for cellular motility and lamellipodia protrusion. When cultured fibroblasts or microvascular endothelial cells are exposed to both peptides simultaneously in preclinical models, researchers observe enhanced speed of wound closure in scratch assays compared to isolated mono-therapies.

Furthermore, animal study models investigating tendon-to-bone interface healing suggest that BPC-157 stabilizes local collagen type I synthesis while TB-500 facilitates rapid cell migration into damaged structural matrices. Evaluating both agents within a controlled 2mg co-lyophilized format eliminates baseline concentration variance during multi-target signaling experiments.

Reconstitution Mathematics for 2mg Lyophilized Vials

Accurate reconstitution is vital for maintaining target molar ratios and reproducible dosing in micro-plate protocols. A 2mg total mass vial of Wolverine Blend contains 1.0 mg of BPC-157 and 1.0 mg of TB-500. Adding a specified volume of laboratory-grade diluent—such as Sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile 0.9% Normal Saline—yields predictable combined and individual peptide concentrations.

Below are the calculated concentrations based on common diluent volumes introduced into a 2mg total mass vial:

1.0 mL Diluent Addition: Yields a total peptide concentration of 2.0 mg/mL (1.0 mg/mL BPC-157 + 1.0 mg/mL TB-500). Every 0.1 mL (100 µL) drawn contains 200 µg total mass (100 µg BPC-157 / 100 µg TB-500).

2.0 mL Diluent Addition: Yields a total peptide concentration of 1.0 mg/mL (0.5 mg/mL BPC-157 + 0.5 mg/mL TB-500). Every 0.1 mL (100 µL) drawn contains 100 µg total mass (50 µg BPC-157 / 50 µg TB-500).

3.0 mL Diluent Addition: Yields a total peptide concentration of 0.667 mg/mL (0.333 mg/mL BPC-157 + 0.333 mg/mL TB-500). Every 0.1 mL (100 µL) drawn contains approximately 66.7 µg total mass (33.3 µg BPC-157 / 33.3 µg TB-500).

To quickly verify custom micro-volume dilutions, laboratory technicians can cross-reference calculations using our interactive laboratory reconstitution calculator.

Step-by-Step Reconstitution Protocol for Laboratory Technicians

To prevent shear stress degradation of the tertiary peptide structures during solvent integration, laboratory personnel should adhere to the following standardized procedure:

1. Remove the protective flip-off cap from the 2mg Wolverine Blend vial and wipe the rubber septum with an aseptic 70% isopropyl alcohol swab. Allow the septum to air-dry completely under a laminar flow hood.

2. Using a sterile micro-syringe, draw up the exact required volume of laboratory diluent (e.g., 1.0 mL or 2.0 mL of Bacteriostatic Water).

3. Position the needle tip against the inner glass wall of the vial. Slowly depress the plunger, allowing the liquid to stream down the side of the glass wall rather than squirting directly onto the delicate lyophilized cake.

4. Allow the vacuum inside the vial to gently draw the liquid if pre-pressurized, or introduce air balance manually using standard aseptic technique.

5. Gently roll the vial between the palms or swirl smoothly in a circular motion until the lyophilized powder is completely dissolved. NEVER shake or vortex the vial, as vigorous mechanical agitation induces peptide denaturation and aggregation.

6. Inspect the reconstituted solution visually under bright illumination. The resulting solution must be clear, colorless, and entirely free of suspended particulate matter or cloudiness before pipetting into experimental assays.

Analytical Quality Control: Lot-Matched COA, HPLC & Endotoxin Limits

PX1 Research enforces strict analytical standards to guarantee lot-to-lot consistency and eliminate confounding variables in preclinical research. Every batch of Wolverine Blend undergoes comprehensive testing at an independent ISO 17025 accredited analytical facility prior to distribution.

Quality assurance protocols require verified high-performance liquid chromatography (HPLC) to confirm that both BPC-157 and TB-500 demonstrate individual purity levels exceeding 99.0% (area under the curve at UV 214 nm). Mass Spectrometry (MS) analysis confirms the precise molecular weight profile for each co-lyophilized constituent, verifying the absence of truncated sequences, deletion peptides, or residual counter-ion impurities.

Furthermore, because bacterial endotoxins can disrupt sensitive tissue culture models and animal cell signaling pathways, every lot is subjected to Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing. PX1 Research guarantees endotoxin levels strictly below <0.05 EU/mg. Verified lot-specific analytical certificates can be directly retrieved through our public Certificate of Analysis library.

Comparative Analysis: BPC-157/TB-500 vs. GHK-Cu and KPV in Cell Migration Assays

When designing multi-arm preclinical trials investigating cellular repair pathways, researchers frequently compare or combine the BPC-157/TB-500 blend with other well-characterized signal peptides. Understanding the distinct biochemical targets of each compound allows for precise experimental control setup.

While the Wolverine Blend acts primarily through actin-cytoskeletal restructuring (TB-500) and VEGFR2/FAK activation (BPC-157), the GHK-Cu copper peptide operates by modulating metalloproteinase activity, stimulating collagen structural synthesis, and regulating gene expression across broad tissue remodeling networks. Conversely, the KPV research peptide—a tripeptide derivative of alpha-MSH—operates predominantly through the suppression of NF-κB inflammatory pathways and nuclear translocation of pro-inflammatory cytokines.

In cell migration and wound-healing scratch assays, combining BPC-157 + TB-500 typically accelerates early endothelial cell motility, whereas GHK-Cu enhances late-stage extracellular matrix deposition and structural cross-linking. Researchers interested in broader signaling cross-talk can examine detailed mechanistic reviews across our preclinical research library.

Storage Parameters & Stability Metrics for Lyophilized vs. Reconstituted Solutions

Maintaining correct temperature and environmental controls is essential to preserve the structural integrity of both BPC-157 and TB-500 in laboratory environments.

Lyophilized Storage (Unopened Vials): Store unopened 2mg Wolverine Blend vials in a dedicated freezer at -20°C (-4°F) for short- to medium-term storage (up to 12 months), or at -80°C (-112°F) for extended multi-year research storage. Ensure vials are kept in desiccated, light-protected containers to prevent moisture accumulation and photo-degradation.

Reconstituted Storage (Liquid Solution): Once reconstituted with Bacteriostatic Water, store the vial under refrigerated conditions at 2°C to 8°C (36°F to 46°F). Reconstituted solutions containing preservative retain verified chemical stability for up to 28 days under refrigerated storage. If reconstituted with unpreserved sterile water or saline, aliquots must be used immediately or discarded after single-session protocol execution.

Avoid repetitive freeze-thaw cycles of reconstituted liquid, as phase-transition ice crystal formation breaks fragile peptide bonds and leads to rapid potency loss.

Selecting Appropriate Vial Masses: 2mg Micro-Scale vs. 10mg High-Throughput Formulations

Choosing between a 2mg total mass format and a larger 10mg catalog formulation depends entirely on the scale and duration of the planned laboratory assay.

The 2mg total mass configuration (1mg BPC-157 / 1mg TB-500) is ideal for pilot screening, single 96-well microplate cellular motility assays, or short-term in vitro receptor binding studies where minimizing leftover reagent reconstituted in storage is paramount.

Conversely, multi-week rodent model studies, high-throughput automated liquid handling screens, or multi-departmental core facility projects benefit from larger formats like the standard 5mg BPC-157 / 5mg TB-500 Wolverine Blend. Selecting the larger combined mass reduces overall vial preparation overhead and ensures consistent solvent batching across expansive longitudinal experimental schedules.